These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10526758)

  • 1. Rethinking the diabetes prevention program clinical trial.
    Singer F
    Diabetes Care; 1999 Oct; 22(10):1757. PubMed ID: 10526758
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin.
    Bloomgarden ZT
    Diabetes Care; 1995 Jul; 18(7):1078-80. PubMed ID: 7555549
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.
    Walker EA; Molitch M; Kramer MK; Kahn S; Ma Y; Edelstein S; Smith K; Johnson MK; Kitabchi A; Crandall J
    Diabetes Care; 2006 Sep; 29(9):1997-2002. PubMed ID: 16936143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].
    Janka HU
    Internist (Berl); 2000 Jul; 41(7):688-9. PubMed ID: 10929259
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-load hyperglycaemia-an inappropriate therapeutic target.
    Yudkin JS
    Lancet; 2002 Jan; 359(9301):166-7. PubMed ID: 11809285
    [No Abstract]   [Full Text] [Related]  

  • 8. The diabetes prevention program: evaluation and management of diabetes. Response to Adler and Turner and Singer et al The DPP Research Group.
    Diabetes Care; 1999 Oct; 22(10):1757-8. PubMed ID: 10526759
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some considerations on the Consensus of the Spanish Diabetes Society and the Spanish Society of Family and Community Medicine on the criteria and guidelines for combined therapy for type 2 diabetes].
    González-Clemente JM; Giménez-Pérez G; Caixàs A; Mauricio D
    Aten Primaria; 2001 Nov; 28(9):624-5. PubMed ID: 11747781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
    Pinto D; Heleno B; Gallego R; Santos I; Santiago LM; Maria V
    Acta Med Port; 2011; 24(2):331-8. PubMed ID: 22011607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of the United Kingdom Prospective Diabetes Study.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S27-31. PubMed ID: 12017673
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)].
    Standl E; Nitschmann S
    Internist (Berl); 2007 Oct; 48(10):1173-6. PubMed ID: 17846732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin for prevention of type 2 diabetes.
    Hess AM; Sullivan DL
    Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and fatty acids.
    Muntoni S
    Diabetes Care; 1999 Jan; 22(1):179-80. PubMed ID: 10333929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.